Zearalenone (ZEN) and Deoxynivalenol (DON) Mycotoxicosis
A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Mycotoxins".
Deadline for manuscript submissions: closed (31 March 2021) | Viewed by 9016
Special Issue Editor
Interests: mycotoxins; detection; feed; mycotoxicosis; immunology; diagnostics; animal pathology
Special Issue Information
Dear Colleagues,
Mycotoxicosis is the name given to the group of illnesses and disorders in humans and animals resulting from toxic secondary metabolites (mycotoxins) produced by some fungi species. Mycotoxicoses are acute and chronic toxic diseases. Their clinical features, target organs, and outcome depend on the intrinsic toxic features of the mycotoxin and the quantity and length of exposure, as well as the health status of the exposed animals. The most prevalent mycotoxins are produced by Fusarium which can produce mycotoxicosis, i.e., zearalenone (ZEN) and deoxynivalenol (DON). DON is known to elicit gastrointestinal disorders and immune suppression, whereas zearalenone creates estrogenic disturbances and shifts the immune response. For this reason, the Special Issue of Toxins will focus on the responses of different bodily systems in animals to various doses of DON or/and ZEN causing mycotoxicosis. We look forward to receiving your contributions for this Special Issue, in the form of original research, case studies, or review papers, shedding new light on DON and ZEN implications for disease developments in animals under realistic conditions.
Prof. Dr. Kazimierz Obremski
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- deoxynivalenol
- zearalenone
- toxic effects
- mycotoxicosis
- gastrointestinal tract
- reproductive system
- immunomodulation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
